The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response
Open accessAbstract
Epstein-Barr virus (EBV), a human γ-herpesvirus, can establish both nonproductive (latent) and productive (lytic) infections. Although the CD8+ cytotoxic T lymphocyte (CTL) response to latently infected cells is well characterized, very little is known about T cell controls over lytic infection; this imbalance in our understanding belies the importance of virus-replicative lesions in several aspects of EBV disease pathogenesis. The present work shows that the primary CD8+ CTL response to EBV in infectious mononucleosis patients contains multiple lytic antigen-specific reactivities at levels at least as high as those seen against latent antigens; similar reactivities are also detectable in CTL memory. Clonal analysis revealed individual responses to the two immediate early proteins BZLF1 and BRLF1, and to three (BMLF1, BMRF1, and BALF2) of the six early proteins tested. In several cases, the peptide epitope and HLA-restricting determinant recognized by these CTLs has been defined, one unusual feature being the number of responses restricted through HLA-C alleles. The work strongly suggests that EBVreplicative lesions are subject to direct CTL control in vivo and that immediate early and early proteins are frequently the immunodominant targets. This contrasts with findings in α- and β-herpesvirus systems (herpes simplex, cytomegalovirus) where viral interference with the antigen-processing pathway during lytic infection renders immediate early and early proteins much less immunogenic. The unique capacity of γ-herpesvirus to amplify the viral load in vivo through a latent growth-transforming infection may have rendered these agents less dependent upon viral replication as a means of successfully colonizing their hosts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
Self-citationEpstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,593
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Whitley, R. J., Kimberlin, D. W., & Roizman, B. (1998) · Clinical Infectious Diseases · doi:10.1086/514600 · Cited by 1,149
Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., & Ploegh, H. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81054-5 · Cited by 1,072
Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V., & Freese, U. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132502 · Cited by 805
Herpes simplex virus turns off the TAP to evade host immunity
Hill, A., Jugovic, P., York, L., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., & Johnson, D. (1995) · Nature · doi:10.1038/375411a0 · Cited by 803
HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
Rickinson, A. B., & Moss, D. J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.405 · Cited by 747
Self-citationHerpes simplex virus turns off the TAP to evade host immunity
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90181-7 · Cited by 736
Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., & Pagano, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405103101905 · Cited by 723
A viral inhibitor of peptide transporters for antigen presentation
Früh, K., Ahn, K., Djaballah, H., Sempé, P., van Endert, P. M., Tampé, R., Peterson, P. A., & Yang, Y. (1995) · Nature · doi:10.1038/375415a0 · Cited by 602
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes
York, I. A., Roop, C., Andrews, D. W., Riddell, S. R., Graham, F. L., & Johnson, D. C. (1994) · Cell · doi:10.1016/0092-8674(94)90215-1 · Cited by 559
Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E., & Rickinson, A. B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.157 · Cited by 499
Self-citationTierney, R. J., Steven, N., Young, L. S., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7374-7385.1994 · Cited by 482
Self-citationLarge clonal expansions of CD8+ T cells in acute infectious mononucleosis
Callan, M. F. C., Steven, N., Krausa, P., Wilson, J. D. K., Moss, P. A. H., Gillespie, G. M., Bell, J. I., Rickinson, A. B., & McMichael, A. J. (1996) · Nature Medicine · doi:10.1038/nm0896-906 · Cited by 473
Self-citationKhanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E., & Moss, D. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.169 · Cited by 384
Self-citationA re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals
Yao, Q. Y., Rickinson, A. B., & Epstein, M. A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350107 · Cited by 338
Self-citationSynchronous and sequential activation of latently infected Epstein-Barr virus genomes
Takada, K., & Ono, Y. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.445-449.1989 · Cited by 331
Townsend, A., Bastin, J., Gould, K., Brownlee, G., Andrew, M., Coupar, B., Boyle, D., Chan, S., & Smith, G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.4.1211 · Cited by 327
Jones, T. R., Hanson, L. K., Sun, L., Slater, J. S., Stenberg, R. M., & Campbell, A. E. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4830-4841.1995 · Cited by 284
Gilbert, M. J., Riddell, S. R., Plachter, B., & Greenberg, P. D. (1996) · Nature · doi:10.1038/383720a0 · Cited by 279
Borysiewicz, L. K., Hickling, J. K., Graham, S., Sinclair, J., Cranage, M. P., Smith, G. L., & Sissons, J. G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.3.919 · Cited by 246
Riddell, S. R., Rabin, M., Geballe, A. P., Britt, W. J., & Greenberg, P. D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.8.2795 · Cited by 226
Young, L. S., Lau, R., Rowe, M., Niedobitek, G., Packham, G., Shanahan, F., Rowe, D. T., Greenspan, D., Greenspan, J. S., & Rickinson, A. B. (1991) · Journal of Virology · doi:10.1128/jvi.65.6.2868-2874.1991 · Cited by 226
Self-citationPearson, G. R., Luka, J., Petti, L., Sample, J., Birkenbach, M., Braun, D., & Kieff, E. (1987) · Virology · doi:10.1016/0042-6822(87)90055-9 · Cited by 183
Epstein‐barr virus‐infected b cells persist in the circulation of acyclovir‐treated virus carriers
Yao, Q. Y., Ogan, P., Rowe, M., Wood, M., & Rickinson, A. B. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430115 · Cited by 178
Self-citationAn Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
Burrows, S. R., Sculley, T. B., Misko, I. S., Schmidt, C., & Moss, D. J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.345 · Cited by 170
Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C.
Zemmour, J., & Parham, P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.937 · Cited by 169
Steven, N. M., Leese, A. M., Annels, N. E., Lee, S. P., & Rickinson, A. B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1801 · Cited by 168
Self-citationT cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.
Scotet, E., David-Ameline, J., Peyrat, M. A., Moreau-Aubry, A., Pinczon, D., Lim, A., Even, J., Semana, G., Berthelot, J. M., Breathnach, R., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1791 · Cited by 167
Egan, J. J., Stewart, J. P., Hasleton, P. S., Arrand, J. R., Carroll, K. B., & Woodcock, A. A. (1995) · Thorax · doi:10.1136/thx.50.12.1234 · Cited by 166
An Epstein-Barr virus-associated superantigen.
Sutkowski, N., Palkama, T., Ciurli, C., Sékaly, R., Thorley‐Lawson, D. A., & Huber, B. T. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.971 · Cited by 136
Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells
Biggin, M. D., Bodescot, M., Perricaudet, M., & Farrell, P. J. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3120-3132.1987 · Cited by 133
Bogedain, C., Wolf, H. J., Modrow, S., Stuber, G., & Jilg, W. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4872-4879.1995 · Cited by 122
Gilbert, M. J., Riddell, S., Li, C. R., & Greenberg, P. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3461-3469.1993 · Cited by 112
Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3
Burrows, S. R., Gardner, J., Khanna, R., Steward, T. W., Moss, D. J., Rodda, S. J., & Suhrbier, A. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-9-2489 · Cited by 103
Tigges, M. A., Koelle, D. M., Hartog, K., Sekulovich, R. E., Corey, L., & Burke, R. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1622-1634.1992 · Cited by 101
Hill, A. B., Lee, S. P., Haurum, J. S., Murray, N., Yao, Q. Y., Rowe, M., Signoret, N. Y. M., Rickinson, A. B., & McMichael, A. J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2221 · Cited by 90
Self-citationWHITE, C. A., Cross, S., Kurilla, M. G., et al. (1996) · Virology · doi:10.1006/viro.1996.0277 · Cited by 42
Self-citation
Cited by
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892
“We made phycoerythrin-labeled tetrameric complexes of HLA A2 folded with the GLCTLVAML peptide from the EBV lytic protein BMLF1 (13, 14) and of HLA B8 folded with the RAKFKQLL epitope from the EBV lytic protein BZLF1 (13, 15) and with the FLRGRAYGL epitope from the EBV latent protein EBNA 3A (16).”
InfluentialSelf-citationCellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Self-citation
Metadata
- Authors
- Steven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., & Rickinson, A. B.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-05-05
- Volume
- 185
- Issue
- 9
- Pages
- 1605-1618
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2149745130
- Cited by
- 350
- References
- 40
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.